We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00803218
First Posted: December 5, 2008
Last Update Posted: March 16, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Perrigo Company
  Purpose
The purpose of this study was to compare the relative vasoconstrictive effects of test and reference topical Fluticasone Propionate 0.005% Ointments in healthy, female subjects.

Condition Intervention
Healthy Drug: Fluticasone Propionate 0.005% Ointment-Reference Product Drug: Fluticasone Propionate 0.005% Ointment-Test product

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Bioequivalence of Two Fluticasone Propionate 0.005% Topical Ointments

Resource links provided by NLM:


Further study details as provided by Perrigo Company:

Primary Outcome Measures:
  • Vasoconstriction will be measured by the degree of skin blanching observed after treatment removal using a ChromaMeter [ Time Frame: Over the course of one day ]

Enrollment: 56
Study Start Date: November 2002
Study Completion Date: November 2002
Primary Completion Date: November 2002 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Cohort Group 1
Subjects number 1 to 26
Drug: Fluticasone Propionate 0.005% Ointment-Reference Product
Small amount applied and evaluated over the course of one day
Drug: Fluticasone Propionate 0.005% Ointment-Test product
Small amount applied and evaluated over the course of one day
Cohort Group 2
Subjects number 27 to 56
Drug: Fluticasone Propionate 0.005% Ointment-Reference Product
Small amount applied and evaluated over the course of one day
Drug: Fluticasone Propionate 0.005% Ointment-Test product
Small amount applied and evaluated over the course of one day

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy Community Volunteers
Criteria

Inclusion Criteria:

  • Non-tobacco using female subjects, 18 to 50 years of age
  • Demonstrated blanching response to Reference Drug
  • Weight within +/- 20% from normal for height and weight for body frame
  • Good health as determined by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator
  • Signed and dated informed consent form which meets all criteria of current FDA regulations

Exclusion Criteria:

  • History of allergy to systemic or topical corticosteroids
  • Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching
  • Presence of medical condition requiring regular treatment with prescription drugs
  • Drug or alcohol addiction requiring treatment in the past 12 months prior to dosing
  • Use of any tobacco products in the 30 days prior to study dosing
  • Use of any dermatological drug therapy on the flexor surface of the forearms within 30 days of dosing
  • Receipt of any drugs as part of a research study within 30 days prior to study dosing
  • Pregnant or lactating
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Linda Gans, Perrigo
ClinicalTrials.gov Identifier: NCT00803218     History of Changes
Other Study ID Numbers: 10216916
First Submitted: December 2, 2008
First Posted: December 5, 2008
Last Update Posted: March 16, 2012
Last Verified: March 2012

Keywords provided by Perrigo Company:
Bioequivalence
Fluticasone Propionate

Additional relevant MeSH terms:
Fluticasone
Anti-Inflammatory Agents
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Asthmatic Agents
Respiratory System Agents
Dermatologic Agents
Anti-Allergic Agents